{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:48:52Z","timestamp":1648684132659},"reference-count":0,"publisher":"BMJ","issue":"mar22 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2012,3,22]]},"DOI":"10.1136\/bmj.e2274","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T11:59:13Z","timestamp":1332503953000},"page":"e2274-e2274","source":"Crossref","is-referenced-by-count":1,"title":["NICE backs leukaemia drug after manufacturer drops price"],"prefix":"10.1136","volume":"344","author":[{"given":"J.","family":"Wise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,3,22]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.e2274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:28:58Z","timestamp":1601080138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.e2274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,22]]},"references-count":0,"journal-issue":{"issue":"mar22 2","published-online":{"date-parts":[[2012,3,22]]},"published-print":{"date-parts":[[2012,3,22]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.e2274","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,22]]}}}